Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study

作者：Gang An, Jie Jin, Zhen Cai, Hongmei Jing, Chengcheng Fu, Pengcheng He, Zhongjun Xia, Rui Liu, Li Liang, Xue Gai, Hong Zhang, Dian Zhu, Xinchao Luo, Binbin Sun, Hongmei Xu, Longen Zhou, Michela Campagna, Tara Masterson, Bonnie Lau, Thomas Renaud, Christoph Heuck, Indrajeet Singh, Deeksha Vishwamitra, Lugui Qiu · 发表于：Haematologica · 年份：2025 · DOI：10.3324/haematol.2025.287334 · 被引用次数：4 · 研究领域：Multiple Myeloma Research and Treatments、Monoclonal and Polyclonal Antibodies Research、HER2/EGFR in Cancer Research

Not available.